1000285-23-3Relevant academic research and scientific papers
Novel pyridyl nitrofuranyl isoxazolines show antibacterial activity against multiple drug resistant Staphylococcus species
Picconi, Pietro,Prabaharan, Priya,Auer, Jennifer L.,Sandiford, Stephanie,Cascio, Francesco,Chowdhury, Madiha,Hind, Charlotte,Wand, Matthew E.,Sutton, J. Mark,Rahman, Khondaker M.
, p. 3971 - 3979 (2017)
A novel series of pyridyl nitrofuranyl isoxazolines were synthesized and evaluated for their antibacterial activity against multiple drug resistant (MDR) Staphylococcus strains. Compounds with piperazine linker between the pyridyl group and isoxazoline ri
Discovery of novel isoxazolines as anti-tuberculosis agents
Tangallapally, Rajendra P.,Sun, Dianqing,Rakesh,Budha, Nageshwar,Lee, Robin E.B.,Lenaerts, Anne J.M.,Meibohm, Bernd,Lee, Richard E.
, p. 6638 - 6642 (2008/03/18)
Nitrofuranyl isoxazolines with increased proteolytic stability over nitrofuranyl amides were designed and synthesized leading to discovery of several compounds with potent in vitro anti-tuberculosis activity. However, their in vivo activity was limited by
